Excuse cross postings.
We are announcing the
program and calling for participants for ChemAxon's 5th US User Group Meeting
(US-UGM) which will take place on September 25-26th in Wellesley, MA. For the
satellite One to One and One to Many topic sessions (Sept 24th) and Training
(Sept 27th) sessions see details below
Highlights of the
event:
- Program is launched with presentations from industry users
including;
Boehringer Ingelheim, BMS, Broad Inst, Eli Lilly, GSK, NIH, Novartis,
Pearson, Takeda and Wiley. Full presentation titles below.
- Program:
http://www.chemaxon.com/events/ugm-boston-2012/#program
- The
UGM is followed by a training day (Sept 27th) with two different tracks: one for
developers and the other for end users.
- Prior to the UGM, on the
afternoon of Sept 24th, we host an afternoon of One to One meetings for users
and 2 focused One to Many sessions for Biologics Registration and
SharePoint.
- Well regarded on and off site socials for networking
and to keep the ideas moving.
I hope you can join us for what, I think,
is our best program yet.
BR
Alex
Useful links:
Program:
http://www.chemaxon.com/events/ugm-boston-2012/#programMore
information:
http://www.chemaxon.com/events/ugm-boston-2012/#overviewRegistration:
http://www.chemaxon.com/events/ugm-boston-2012-registration/One
to One & One to Many Sessions:
http://www.chemaxon.com/events/ugm-boston-2012/#onetomanyDeveloper
Training:
http://www.chemaxon.com/events/ugm-boston-2012/#developerEnd
user training details:
http://www.chemaxon.com/events/ugm-boston-2012/#appfocusUGM
archives - slides and video and meeting reports from Wendy Warr and Yvonne
Martin:
http://www.chemaxon.com/ugm-archive/Program: User
Presentation titles and Institutions
01 Chemistry
Infrastructure Migration in Global Pharmaceutical Company: Concerns and
Reality. Zhenbin (Benjamin) Li, Boehringer
Ingelheim
02 Patent Analytics for Drug Discovery via
Instant JChem. Dana Vanderwall, Bristol-Myers
Squibb
03 Keynote: Future-proofing - managing systems in
rapidly changing times. Ramesh Durvasula & Alex Drijver,
Bristol-Myers Squibb & ChemAxon
04 Development of a
Stereochemical Structure-Activity Relationships Viewer to Analyze HTS Data
Generated from DOS Compound Collections. Carol Mulrooney,
Broad Institute
05 Assisted Data Exploration in Chemical
Biology. Dennis Moccia, Cognative Data
Works
06 The Lilly Open Innovation Drug Discovery
Program. Daniel Robertson, Eli Lilly
07
Registration as a service: The full story after half-year.
Rama Bhamidipati & Akos Papp, GSK & ChemAxon
08
Advances in text mining for chemical information: an update on the ChiKEL
project. David Milward, Daniel Bonniot, Linguamatics &
ChemAxon
09 Cloudy with a touch of
Cheminformatics. Rajarshi Guha, NIH -
NCGI
10 Migrating away from ISIS with ChemAxon's
help. Debra Kassabian, Novartis
11 An
approach to developing a Compound Registration system using JChem Base and JChem
Cartridge. Bob Trucchi, Nuova Stella
12
Pearson Education and ChemAxon: Partnership to develop educational
MarvinSketch. Jeanne Zalesky, Pearson
Education
13 GPCR Informatics: Structure/Properties and
Pharmacological Correlations. Danni Harris, RTI
International
14 Compound Progression Workflow
Process. Matthew Pustelnik, Takeda
California
15 Just Another Chemical Query (ChemQ) Tool or
Not. Matthew Pustelnik, Takeda
California
16 Compounds for indications, indications for
compounds. John Irwin, UCSF
17 Enhancing
the User Experience for Wiley Chemistry Content. Neil Pearson,
Wiley
Alex Allardyce
Marketing Dir.
ChemAxon
Ltd
ZÃhony u. 7. Building HX, Budapest, 1031 Hungary
http://www.chemaxon.comTel: +361 453 0435
Fax: +361
4532659